Enzyme Replacement Therapy Medicines

Award

Description

Supply of Enzyme Replacement Therapy Medicines (a-d) to NHS Scotland:
- NP92624(a) Laronidase 500units/5ml solution for infusion vials 1 vial (Aldurazyme®)
- NP92624(b) Imiglucerase 400unit powder for solution for infusion vials 1 vial (Cerezyme®)
- NP92624(c) Agalsidase beta 35mg powder for solution for infusion vials 1 vial (Fabrazyme®)
- NP92624(c) Agalsidase beta 5mg powder for solution for infusion vials 1 vial (Fabrazyme®)
- NP92624(d) Alglucosidase alfa 50mg powder for solution for infusion vials 1 vial (Myozyme®)

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete